CN1267108C - Medication for treating painful symptoms of the illness - Google Patents

Medication for treating painful symptoms of the illness Download PDF

Info

Publication number
CN1267108C
CN1267108C CN 200410022334 CN200410022334A CN1267108C CN 1267108 C CN1267108 C CN 1267108C CN 200410022334 CN200410022334 CN 200410022334 CN 200410022334 A CN200410022334 A CN 200410022334A CN 1267108 C CN1267108 C CN 1267108C
Authority
CN
China
Prior art keywords
pain
treatment
swelling
illness
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200410022334
Other languages
Chinese (zh)
Other versions
CN1562224A (en
Inventor
徐和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUIZHOU JINGCHENG PHARMACEUTICAL CO., LTD.
Original Assignee
ANTAI PHARMACEUTICAL Co Ltd GUIZHOU PROV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANTAI PHARMACEUTICAL Co Ltd GUIZHOU PROV filed Critical ANTAI PHARMACEUTICAL Co Ltd GUIZHOU PROV
Priority to CN 200410022334 priority Critical patent/CN1267108C/en
Publication of CN1562224A publication Critical patent/CN1562224A/en
Application granted granted Critical
Publication of CN1267108C publication Critical patent/CN1267108C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a medicament for treating painful symptoms of diseases and a preparation technology thereof. The medicament is singly prepared from willmott ceratosigma root. The present invention has the advantages of long lasting time for relieving pain, low price, no toxic or side effect, simple technology and the like. The medicament can be used for treating disease symptoms of postoperative pain, pains of knocks and falls, and the like.

Description

The tablet of treatment antalgesic
Technical field:
The present invention relates to the medicine of the treatment antalgesic that the single flavor Chinese herbal medicine of a kind of usefulness makes.
Technical background:
Growing blood stasis, meridians resistance by gas, to grow all kinds of antalgesics such as extremely postoperative pain of institute, traumatic pain be common disease, and the medicine for the treatment of generally has plaster at present, and oral agents is also arranged.But great majority all are the compound recipe dosage forms, and are also rare with the medicine of single prescription, and exist the pain relief persistent period short, problems such as price height.
Summary of the invention:
The objective of the invention is to: a kind of usefulness preparation that single herbal medicine is made is provided, its good effect, low price is to satisfy the needs of extensive patients.
The present invention is achieved in that it is the preparation made from Radix ceratostigmatis willemottiani list Herba indigoferae Pseudotinctoriae.
Described preparation is a tablet.
Its preparation method is: to produce 1000, get Radix ceratostigmatis willemottiani 300~800g, decoct with water secondary, each 2 hours, collect distillate, cold preservation is more than 48 hours, the collection crystallization is deposited standby in addition, and collecting decoction filters, it is 1.33 that filtrate is concentrated into relative density, puts the crystal that cold back adds above-mentioned collection, stirs evenly, add an amount of adjuvant, mixing, drying, be pressed into 1000, coating promptly.
Radix ceratostigmatis willemottiani is warm in nature, sweet in the mouth.Has promoting blood circulation and stopping pain, the effect of blood stasis dispersing and fresh blood promoting.
Advantages such as the present invention compared with prior art has the alleviating pain longer duration, and price is low, has no side effect, and technology is simple.Can treat diseases such as postoperative pain, traumatic pain.Concrete clinical summary is as follows:
One, research method
(1), case is selected
1. tcm diagnosis standard
Acute periankle injury: different forms of violence causes the damage of ankle muscle, comprise fascia, tendon,
Ligament, and tissue such as subcutaneous tissue, part muscle, arthritis.
Acute trauma history is arranged: ankle soft tissue swelling, pain, ecchymosis, dysfunction; The X ray examination does not have fracture.
2. differential diagnosis in tcm standard
Qi stagnation and blood stasis type: acute trauma history is arranged, ankle swelling, ecchymosis or local pyrexia, pain with tenderness, localized pain, function limitation, pale tongue or dark partially, thin fur is white or yellow, the puckery or summary number of arteries and veins or string.
3. Western medicine diagnose standard
Acute soft tissue injury of ankles: comprise contusion (directly external force is hit or collided the limbs part, causes subcutaneous tissue of ankle, muscle, tendon equivalent damage) and sprain that (indirect violence makes limbs and periarticular fascia, muscle.Ligament hyperflexion, tractive cause the damage of surrounding soft tissue or tear).
4. include the case standard in
(1) the acute soft tissue injury course of disease is no more than 3 days;
(2) meet Western medicine diagnose standard and differential diagnosis in tcm standard person;
(3) age is at 18-65 between year.
5. get rid of case standard (comprising incompatibility or rejecting standard)
(1) above-mentioned symptom person due to the non-acute soft tissue injury of ankles;
(2) took relevant analgesic drug product person after the wound;
(3) age under-18s or over-65s person;
(4) gestation or women breast-feeding their children are to this medicine allergy sufferers;
(5) intentionally, important organ severe dysfunction persons such as liver, kidney;
(6) do not meet the standard of including in, non-curative effect reason, also non-untoward reaction and drug withdrawal person midway, and not medication in accordance with regulations can't judge that curative effect or data are incomplete, affect the treatment or safety judgement person.
(2), the administrated method and the course of treatment
The Radix ceratostigmatis willemottiani sheet, every day three times, each 2.Three days is a course of treatment.
Reach treatment back pain intensity, pain degree, tenderness, swelling and dysfunction respectively before the record treatment.
(3), observation index
1, pain intensity, (PI)
Help to judge by the patient or the doctor, oneself records with 0-10 numeral pain intensity staging.The no pain of 0 expression, 10 represent that patients think serious pain, and 1-3 mild pain, 4-6 are moderate pain, and 7-9 is a severe pain.
0 1 2 3 4 5 6 7 8 9 10
2. pain degree classification (WTO three step analgesia therapy pain grade scales)
0 grade of (0 minute) no pain;
I level (1 minute): (mild pain) though pain is arranged but still can stand, and can orthobiosis, sleep is interference-free;
II level (2 minutes): (moderate pain) pain is obvious, is impatient at, and needs to use analgesic, and sleep is disturbed;
III level (3 minutes): (severe pain) sharp ache, sleep seriously is interfered, and needs to use analgesic, can be with autonomic nervous dysfunction or positive position.
3. tenderness
No tenderness 0 minute
Mild pain when pushing, no pain expression 1 minute
Pain is heavier when pushing, and painful expression is arranged, and still can stand 2 fens
Sharp ache during flicking, tenderness 3 minutes
4. swelling
No swelling 0 minute
Mild swelling was lower than bone mark 1 minute
Moderate swelling, flat bone mark, dermatoglyph disappeared 2 fens
Severe swelling exceeds bone mark, and severe patient can have blister 3 minutes
5. joint motion
Can do comings and goings 0 minute
Moderate is limited, can take care of oneself, and can be engaged in 1 minute orthobiosis
Obviously limited, can take care of oneself, but can not be engaged in normal activity 2 minutes
The mobility forfeiture, life can not be from 3 minutes
(4), efficacy assessment standard
1. pain intensity poor (PID)
Be before the patient treatment and the difference of treatment back pain intensity, reaction pain relief degree.
2. total effects
Recovery from illness: pain, tenderness, swelling disappear, and joint motion is normal, and integration is 0 minute.
Produce effects: pain, tenderness, swelling obviously alleviate, and joint motion is normal substantially, and integration reduces more than 2/3.
Effectively: pain, tenderness, swelling alleviate to some extent, and joint motion recovers to some extent, and integration reduces more than 1/3.
Invalid: pain, tenderness, swelling, joint motion do not change, and integration reduces below 1/3.
3. safety is observed
There is the gastrointestinal side effect of case in observation post, whether has the secondary work of poison to understand medicine.
Two, clinical data
This is organized 30 routine cases and is outpatient service or emergency case.Male's 18 examples wherein, women's 12 examples, men and women's ratio is 1.5: 1.Minimum 18 years old of age, maximum 60 years old, average 33.88 ± 13.48 years old
Pain degree distributes
n I level (%) II level (%) III level (%)
30 7(23.33%) 21(70%) 2(6.67%)
Three, therapeutic outcome
(1) total effects
n Recovery from illness Produce effects Effectively Invalid Total effective rate
30 2 2 21 5 83.33%
This is organized in the 30 routine cases, 2 examples of fully recovering, produce effects 2 examples, effective 21 examples, invalid 5 examples.Total effective rate 83.33%.
(2), each symptom and sign curative effect
Pain degree Tenderness Swell and ache Joint motion
Before the treatment 1.83±0.53 1.87±0.52 1.20±0.48 1.27±0.45
After the treatment 0.77±0.43 1.06±0.45 0.73±0.64 0.76±0.57
Relatively, expression is through the t check before and after the treatment, and there is significant difference p<0.05.Treat the back and control preceding comparison, pain degree, tenderness, swelling, joint motion all have alleviation.
(3) pain intensity compares before and after the treatment
Pain intensity before the treatment Treatment back pain intensity Pain intensity is poor before and after the treatment
4.55±1.11 1.43±1.14 3.00±1.05
Relatively, expression is through the t check before and after patient's statement treatment, and there is significant difference p<0.05.The treatment back is relatively preceding with treatment, and pain intensity alleviates.
(4) relation of pain degree and curative effect
Pain degree n Recovery from illness Produce effects Effectively Invalid Effective percentage
I 7 1 0 5 1 85.71%
II 21 1 2 15 4 85.71%
III 2 0 2 0 0 100%
Through X 2P>0.05, no difference of science of statistics are compared in check between three groups.Show that pain degrees at different levels and curative effect do not have dependency.
(5) safety is observed
In the 30 routine cases, finding no bad of tangible gastrointestinal tract should.
Four, discuss
The present invention is used for the treatment of acute ankle sprain 30 examples, 2 examples of fully recovering, produce effects 2 examples, effective 21 examples, invalid 5 examples, total effective rate 83.23%.Symptoms such as the pain that acute ankle sprain is caused, swelling, joint function disturbance are analyzed by statistics, and relatively, there is significant difference P<0.05 before treatment back and the treatment, and treatment back symptom alleviates before the treatment.Pain degree and curative effect do not have dependency, and pain at different levels are all had tangible analgesic effect.Find no tangible gastrointestinal side effect in the therapeutic process.
The specific embodiment:
Embodiments of the invention: to produce 1000 tablets of tablets, get Radix ceratostigmatis willemottiani 500g, decoct with water secondary, each 2 hours, collect distillate, cold preservation was collected crystallization and is deposited standby in addition more than 48 hour; Collecting decoction filters, and it is 1.33 (70 ℃) that filtrate is concentrated into relative density, puts the crystal that cold back adds above-mentioned collection, stirs evenly, and adds an amount of additive of tablet, and mixing is made granule, and drying is pressed into 1000, and the bag film-coat promptly.
The present invention also can make capsule, granule etc. according to common process.

Claims (1)

1, a kind of tablet for the treatment of antalgesic is characterized in that: it is the preparation made from Radix ceratostigmatis willemottiani list Herba indigoferae Pseudotinctoriae; Its consumption is: to produce 1000, Radix ceratostigmatis willemottiani 300~800g; Preparation method is: get Radix ceratostigmatis willemottiani and decoct with water secondary, each 2 hours, collect distillate, cold preservation is more than 48 hours, and the collection crystallization is deposited standby in addition, collecting decoction, filter, it is 1.33 that filtrate is concentrated into relative density, puts the crystal that cold back adds above-mentioned collection, stir evenly, add an amount of adjuvant, mixing, drying, be pressed into 1000, coating promptly.
CN 200410022334 2004-04-15 2004-04-15 Medication for treating painful symptoms of the illness Expired - Fee Related CN1267108C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410022334 CN1267108C (en) 2004-04-15 2004-04-15 Medication for treating painful symptoms of the illness

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410022334 CN1267108C (en) 2004-04-15 2004-04-15 Medication for treating painful symptoms of the illness

Publications (2)

Publication Number Publication Date
CN1562224A CN1562224A (en) 2005-01-12
CN1267108C true CN1267108C (en) 2006-08-02

Family

ID=34480050

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410022334 Expired - Fee Related CN1267108C (en) 2004-04-15 2004-04-15 Medication for treating painful symptoms of the illness

Country Status (1)

Country Link
CN (1) CN1267108C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101711835B (en) * 2008-10-08 2013-07-03 贵阳医学院 Formula of traditional Chinese medicines for treating soft tissue injury and method for preparing preparation thereof

Also Published As

Publication number Publication date
CN1562224A (en) 2005-01-12

Similar Documents

Publication Publication Date Title
CN1092981C (en) Medicine for curing arthralgia-syndrome resulted from wind,cold and dampness and its preparation method
CN1112424A (en) Toutongning-medicine for headache
CN1267108C (en) Medication for treating painful symptoms of the illness
CN1310664C (en) Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process
CN1814201A (en) Chinese-medicine cataplasma for treating cervical vertebra disease and preparing method
CN1294917C (en) Injection for curing italitai disease and preparation technique
CN1876088A (en) A medicine for treating chronic prostatitis and preparation method thereof
CN1186067C (en) Medicine for curing acute injury of muscle and tendon and its preparation method
CN102357215A (en) Ointment for treating right hypochondriac distention and pain caused by acute and chronic cholecystitis
CN1911294A (en) Medicine for treating cervical spondylosis and lumba vertebrae disease
CN1723933A (en) Traditional Chinese medicine capsule for treating application, and its prodn. method
CN101199601B (en) Naze rheumatism medicated liquor
CN1686194A (en) Medicine for treating hemicrania and its preparation method
CN1247245C (en) Medicine for treating epilepsy
CN1615949A (en) Medicine for treating epilepsia
CN102961662B (en) Medicine for treating gastric ulcer and preparation method thereof
CN1245211C (en) Medicine for treating chronic gastritis and peptic ulcer
CN1299762C (en) Chinese medicinal preparation for treating atrophic arthritis
CN1088378C (en) Oral Chinese medicine liquid for treating chronic superficial gastritis and its preparation
CN1086295C (en) Exterior-applied medical liquor
CN1839974A (en) Medicine composition for treating rheumatoid disease and method for preparing the same
Huang Clinical Research and Prospects of Huang's Yao Medicine Oil for Postherpetic Sequelae
CN1194753C (en) Medicine for treating head wind syndrome
CN118304347A (en) Fengtong plaster for department of traumatology and preparation method thereof
CN1470254A (en) Chinese medicinal external-use oil preparation for treating skin swelling and ulcer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: GUIZHOU JINGCHENG PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: ANTAI PHARMACEUTICAL CO., LTD., GUIZHOU PROV.

CP03 Change of name, title or address

Address after: 550000 Guizhou city of Guiyang province Xiuwen Industrial Park (Medicine)

Patentee after: GUIZHOU JINGCHENG PHARMACEUTICAL CO., LTD.

Address before: 550001 Guizhou Province, Guiyang city Baoshan Road No. 176 Schwab Vista 9 buildings A

Patentee before: Antai Pharmaceutical Co., Ltd., Guizhou Prov.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060802

Termination date: 20180415